NAGE

$2.36-1.67%visit website

Niagen Bioscience, Inc.

Market Cap

$187M

Live price × SEC shares (Jul 30, 2026)

Sector

Health Care

Industry

Medicinal Chemicals & Botanical Products

Beta (raw)

2.10

60mo monthly vs SPY

P/E (TTM)

12.4

TTM to Jun 2026 · diluted EPS

P/S (TTM)

1.4

TTM to Jun 2026 · revenue

P/B

2.3

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	33,986	33,839	31,474	29,785	129,084
Cost of revenue	12,058	12,135	11,498	10,471	46,162
Gross profit	21,928	21,704	19,976	19,314	82,922
Research & development	1,795	1,710	1,481	1,513	6,499
Total operating expenses	17,692	17,618	18,400	18,614	72,324
Operating income	4,236	4,086	1,576	700	10,598
Pretax income	4,800	4,424	6,735	1,069	17,028
Income tax	222	292	417	106	1,037
Net income	4,578	4,132	6,318	963	15,991
EPS (basic) ($)	0.06		0.08	0.01	0.20
EPS (diluted) ($)	0.05		0.07	0.01	0.19
Weighted avg. shares (basic)	79,779		79,917	79,322
Weighted avg. shares (diluted)	86,619		84,566	82,504

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 4, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jul 2010, with Tormere Pro.

Corporate Events (8-K)

9 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Aug 4, 2026 accepted 4:03 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Jun 29, 2026 accepted 4:30 PM ET	5.07Shareholder vote	Document SEC ↗
May 6, 2026 accepted 4:01 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Mar 19, 2026 accepted 8:34 AM ET	8.01Other events	Document SEC ↗
Mar 4, 2026 accepted 4:01 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Feb 26, 2026 accepted 7:02 AM ET	7.01Reg FD disclosure8.01Other events	Document SEC ↗
Dec 22, 2025 accepted 8:32 AM ET	1.01Material agreement7.01Reg FD disclosure	Document SEC ↗
Nov 6, 2025 accepted 9:05 AM ET	8.01Other events	Document SEC ↗
Nov 4, 2025 accepted 4:01 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Oct 6, 2025 accepted 4:04 PM ET	7.01Reg FD disclosure	Document SEC ↗